Video Experimental Relacionado

Updated: Apr 23, 2026

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
10:11

Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

Published on: September 27, 2014

38.2K

Enfermedades infecciosas. enfermedades. Cuando la protección contra el ébola falla

Jon Cohen

    Science (New York, N.Y.)
    |October 4, 2014
    PubMed
    Resumen

    No abstract available in PubMed .

    Más Videos Relacionados

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    23.0K
    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
    09:04

    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

    Published on: May 11, 2020

    12.7K

    Videos de Experimentos Relacionados

    Last Updated: Apr 23, 2026

    Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
    10:11

    Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes

    Published on: September 27, 2014

    38.2K
    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    23.0K
    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency
    09:04

    In Vitro ELISA Test to Evaluate Rabies Vaccine Potency

    Published on: May 11, 2020

    12.7K

    Videos de Conceptos Relacionados

    Cross-reactivity00:42

    Cross-reactivity

    28.7K
    Overview
    28.7K
    Vaccinations01:51

    Vaccinations

    43.7K
    Overview
    43.7K
    Vaccine Production01:23

    Vaccine Production

    120
    Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
    120
    Vaccines01:21

    Vaccines

    64
    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
    64
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ACERCA DE JoVE
    Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
    AUTORES
    Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
    BIBLIOTECARIOS
    TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
    INVESTIGACIÓN
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
    EDUCACIÓN
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
    Términos y Condiciones de Uso
    Política de Privacidad
    Políticas
    Jove
    Visualize
    Contáctanos